Profile
Christopher M.
Lindblom worked as Secretary, Treasurer, SVP-Finance & Administration at DNIB Unwind, Inc. from 2014 to 2016.
Prior to that, he was Chief Accounting Officer & Vice President-Finance at Infinity Pharmaceuticals, Inc. from 2006 to 2013.
He also worked as Treasurer & Vice President-Finance at Infinity Pharmaceuticals, Inc. in 2016 and at OvaScience, Inc. in 2014.
Lindblom holds an MBA from Boston College and an undergraduate degree from Syracuse University.
Former positions of Christopher M. Lindblom
Companies | Position | End |
---|---|---|
INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2016-07-24 |
DNIB UNWIND INC | Director of Finance/CFO | 2016-03-20 |
INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2013-04-11 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Director of Finance/CFO | 2013-06-06 |
Training of Christopher M. Lindblom
Boston College | Masters Business Admin |
Syracuse University | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
INFINITY PHARMACEUTICALS, INC. | Health Technology |
Private companies | 2 |
---|---|
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
DNIB Unwind, Inc.
DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
- Stock Market
- Insiders
- Christopher M. Lindblom